Thalidomide, Drug Safety, and Off-Label Prescribing

This Viewpoint reviews the Celgene settlement and provides a number of suggestions on how to move forward to address the safety and off-label marketing concerns that were litigated in the case.

https://ift.tt/2rDeZE6